Chongqing Zhifei Biological Products Co., Ltd.
300122
Rang in aandelen
#3690
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Aandeelprijs
$1.91
Marktkapitalisatie
$4.57B
Verandering (1 dag)
5.32%
Verandering (1 jaar)
-32.90%
Land
CN
Handel Chongqing Zhifei Biological Products Co., Ltd. (300122)
Categorie
Healthcare
P/S-ratio voor Chongqing Zhifei Biological Products Co., Ltd. (300122)
P/S-ratio op October 2026 TTM: 3.75
Volgens de meest recente financiële rapporten en aandelenkoers van Chongqing Zhifei Biological Products Co., Ltd. is de huidige P/S-ratio (TTM) 3.75. Eind 2023 had het bedrijf een P/S-ratio van 2.71.
P/S-ratiohistoriek voor Chongqing Zhifei Biological Products Co., Ltd. van 2007 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 3.75 | 54.82% |
| 2024 | 2.42 | -10.83% |
| 2023 | 2.71 | -26.21% |
| 2022 | 3.67 | -15.30% |
| 2021 | 4.34 | -58.25% |
| 2020 | 10.39 | 107.58% |
| 2019 | 5.00 | -32.02% |
| 2018 | 7.36 | -67.72% |
| 2017 | 22.80 | -40.40% |
| 2016 | 38.25 | 41.02% |
| 2015 | 27.13 | 102.50% |
| 2014 | 13.40 | -18.92% |
| 2013 | 16.52 | 42.05% |
| 2012 | 11.63 | 2.40% |
| 2011 | 11.36 | 1.27% |
| 2010 | 11.22 | -52.73% |
| 2009 | 23.73 | -1.38% |
| 2008 | 24.06 | -17.35% |
| 2007 | 29.11 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 10.02 | 167.49% |
US
|
|
| 40.55 | 982.31% |
US
|
|
| 3.96 | 5.72% |
AU
|
|
| 10.15 | 170.81% |
NL
|
|
| - | - |
CH
|
